3-(3-(2-((4-chlorophenyl)sulfonamido)-ethyl)phenyl)propanoic acid

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: 3-(3-(2-((4-chlorophenyl)sulfonamido)-ethyl)phenyl)propanoic acid
• 英文别名: 3-(3-(2-(4-chlorophenylsulfonamido)ethyl)phenyl)propanoic acid；3-[3-[2-[(4-Chlorophenyl)sulfonylamino]ethyl]phenyl]propanoic acid
• 化学式: C₁₇H₁₈ClNO₄S
• 分子量: 367.853
• InChiKey: AGRAPFFXIAIYEB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  24
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  91.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  3-溴苯乙胺 在 palladium 10% on activated carbon 、 氢气 、 palladium diacetate 、 三乙胺 、 三(邻甲基苯基)磷 、 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 7.5h， 生成 3-(3-(2-((4-chlorophenyl)sulfonamido)-ethyl)phenyl)propanoic acid
  参考文献：
  名称：

  Cyclopentane-1,3-dione: A Novel Isostere for the Carboxylic Acid Functional Group. Application to the Design of Potent Thromboxane (A2) Receptor Antagonists

  摘要：

  Cyclopentane-1,3-diones are known to exhibit pK(a) values typically in the range of carboxylic acids. To explore the potential of the cyclopentane-1,3-dione unit as a carboxylic acid isostere, the physical chemical properties of representative congeners were examined and compared with similar derivatives bearing carboxylic acid or tetrazole residues. These studies suggest that cyclopentane-1,3-diones may effectively substitute for the carboxylic acid functional group. To demonstrate the use of the cyclopentane-1,3-dione isostere in drug design, derivatives of a known thromboxane A(2) prostanoid (TP) receptor antagonist, 3-(3-(2-(4-chlorophenylsulfonamido)ethyl)phenyl)propanoic acid (12), were synthesized and evaluated in both functional and radioligand-binding assays. A series of mono- and disubstituted cyclopentane-1,3-dione derivatives (41-45) were identified that exhibit nanomolar IC50 and K-d values similar to 12. Collectively, these studies demonstrate that the cyclopentane-1,3-dione moiety comprises a novel isostere of the carboxylic acid functional group. Given the combination of the relatively strong acidity, tunable lipophilicity, and versatility of the structure, the cyclopentane-1,3-dione moiety may constitute a valuable addition to the palette of carboxylic acid isosteres.

  DOI：

  10.1021/jm200980u

文献信息

• Cycloalkyl-dione Derivatives And Methods Of Their Use
  申请人：Atasoylu Onur

  公开号：US20120329877A1

  公开（公告）日：2012-12-27

  The present invention is directed to compounds of formula I: wherein A is n is 0, 1, or 2; m is 0 or 1; R 1 is H or C 1-6 alkyl and R 2 is H, C 1-6 alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and X is O or N; as well as tautomers and pharmaceutically acceptable salt forms thereof. Uses of these compounds are also described.

  本发明涉及以下式I的化合物：其中A为0、1或2；m为0或1；R1为H或C1-6烷基，R2为H、C1-6烷基、取代或未取代芳基，或取代或未取代杂环芳基；X为O或N；以及它们的互变异构体和药学上可接受的盐形式。还描述了这些化合物的用途。
• CYCLOALKYL-DIONE DERIVATIVES AND METHODS OF THEIR USE
  申请人：THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

  公开号：US20160031805A1

  公开（公告）日：2016-02-04

  The present invention is directed to compounds of formula I: wherein A is n is 0, 1, or 2; m is 0 or 1; R 1 is H or C 1-6 alkyl and R 2 is H, C 1-6 alkyl, C 1-6 alkaryl, aryl, or heteroaryl; and X is O or NH. Tautomers, enantiomers, and diastereomers, as well as pharmaceutically acceptable salt forms, of compounds of formula I are also within the scope of the invention. Methods of preparing and using the compounds of formula I are also described. wherein A is

  本发明涉及公式I的化合物：其中A为n为0、1或2；m为0或1；R1为H或C1-6烷基，R2为H、C1-6烷基、C1-6烷基芳基、芳基或杂环芳基；X为O或NH。公式I的互变异构体、对映异构体和二对映异构体，以及药学上可接受的盐形式也属于本发明的范围。还描述了制备和使用公式I化合物的方法。其中A为
• Dickinson, Roger P.; Dack, Kevin N.; Long, Clive J., Journal of Medicinal Chemistry, 1997, vol. 40, # 21, p. 3442 - 3452
  作者：Dickinson, Roger P.、Dack, Kevin N.、Long, Clive J.、Steele, John

  DOI：——

  日期：——
• US8530520B2
  申请人：——

  公开号：US8530520B2

  公开（公告）日：2013-09-10
• US9643919B2
  申请人：——

  公开号：US9643919B2

  公开（公告）日：2017-05-09